<DOC>
	<DOCNO>NCT01627860</DOCNO>
	<brief_summary>The purpose study examine seizure control tolerability Topiramate either transition previous antiepileptic drug ( AED ) add previous AED .</brief_summary>
	<brief_title>First Add-on vs. Mono-therapy Study Topiramate Neuro-Surgical Patients</brief_title>
	<detailed_description>This multicenter , randomize ( treatment assign chance ) , open-label ( everyone involve trial know study drug ) , parallel group trial . The study three phase : retrospective baseline assessment patient ( 4 week ) , titration period ( 8 week ) maintenance period ( 8 week ) . After qualify trial entry retrospective baseline phase , eligible patient randomize 1:1 ratio receive either topiramate add-on therapy topiramate monotherapy . During titration period ( period dose study drug increase decrease discretion investigator ) , topiramate , give morning dos , start daily dos 25 mg/day one week . After , topiramate give morning evening dos , dose gradually increase every week reach initial target dose 200 mg/day end titration period . During maintenance period , dose topiramate could increase decrease accord investigator 's judgment . Patients keep seizure diaries 16 week topiramate treat period follow monthly visit clinic , safety evaluate .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Must diagnose seizure disorder Have receive concomitant therapy one antiepileptic drug ( AED ) , stable dose prior trial entry Must dissatisfy current treatment Have treatable cause seizure ( eg , metabolic disturbance , toxic exposure , active infection , neoplasm ) Have grade IV astrocytomas , eg , Glioblastoma multiforme ( GBM ) metastases progression Have seizures occur cluster pattern define numerous seizure occur less 30 min Have history ( within past six month ) psychiatric mood disorder require electroconvulsive therapy , major tranquilizer , monoamine oxidase inhibitor Have schizophrenic history exhibit psychotic symptomatology Inability take medication maintain seizure calendar , independently assistance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Neuro-surgical patient</keyword>
	<keyword>Nervous disorder</keyword>
	<keyword>Seizures</keyword>
</DOC>